mossman logo

ABOUT US

       MISSION
       Mossman Associates is devoted to providing the world with the highest quality medical diagnostics, equipment, reagents and services at the most competitive price. Mossman Associates is a complete partner for the biotechnology industry providing services in a number of areas.
       SCIENTIFIC ADVISORY BOARD


       Mr. Donald Mossman is the President of Mossman Associates Inc, which was founded in 2001. Mr. Mossman has almost 3 decades of experience in virtually all aspects of the biotech industry. His exposure runs the complete gamut of activities including Customer service, Manufacturing, Quality Control, Quality Assurance, Research and Development, Marketing, Human Resources, Regulatory Affairs and Finance. The companies he has helped have been as diverse, including manufacturers of such products as home pregnancy tests, reagents to turn off genes, and generic pharmaceuticals.






       HISTORY
       The professionals at Mossman Associates have been pioneering innovations within the medical diagnostic field for over 30 years. In 1970s they were involved with the first coated tube assays using radioimmunoassay (RIA) for measuring small amounts of circulating analytes. In the 1980s, they were involved with the introduction of one of the first home pregnancy and home ovulation tests. Radical for their time these tests are still on the market in new generation formats. In the 1990s, our personnel helped pioneer “gene silencing” using DNA oligos and siRNA. Today these powerful tools are still in use.
In 2001 we at Mossman Associates introduced our first diagnostic products, NicCheckTM and MycoDotTM, which keeping with our tradition were fairly radical products for their times. NicCheck is the first FDA cleared product for the semi-quantitation of nicotine and nicotine metabolites in urine. It remains the only CLIA Waived test for this purpose. MycoDot was the first serology test approved by any governmental agency (the Kosheio in JAPAN) for the rapid testing for active Tuberculosis.